NCT05328856 is a NA clinical trial of Hansgrohe prototype/shower head in General Population, sponsored by Charite University, Berlin, Germany.

Who is sponsoring NCT05328856?

NCT05328856 is sponsored by Charite University, Berlin, Germany.

What drugs are being tested in NCT05328856?

Interventions in NCT05328856: Hansgrohe prototype/shower head.

What condition does NCT05328856 study?

NCT05328856 studies General Population.

Is NCT05328856 still recruiting?

NCT05328856 is currently recruiting now. Last updated 6 March 2025.

Last reviewed 2025-03-06 · How we verify

NCT05328856

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being

Recruiting now NA Last updated 6 March 2025

What this trial tests

NA trial testing Hansgrohe prototype/shower head in General Population in 50 participants. Currently enrolling.

Timeline

25 May 2022

Primary endpoint
30 July 2025

31 December 2025

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	50
Start date	25 May 2022
Primary completion	30 July 2025
Estimated completion	31 December 2025
Sites	1 location across Germany

Drugs / interventions tested

Hansgrohe prototype/shower head

Conditions studied

General Population — all drugs for General Population →

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 18 to 70, any sex, with General Population. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for General Population

Currently open trials in the same condition.

NCT06166810 — Capture of Healthy Gut Bacteria Associated to High Fiber Diet · recruiting
NCT05758961 — Le French Gut: Characterization of Gut Microbiota Profiles in France · recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05328856 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 6 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05328856.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing